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Abstract
Large registries of potential unrelated stem cell donors have been established in order to enable stem cell transplantation
for patients without HLA-identical related donors. Donor search is complicated by the fact that the stored HLA information
of many registered donors is incomplete. We carried out a project that was aimed to improve chances of patients with
ongoing donor searches to find an HLA-matched unrelated donor. For that purpose, we carried out additional donor center-
initiated HLA-DRB1 typing of donors who were only typed for the HLA loci A and B so far and were potential matches for
patients in need of a stem cell transplant. In total, 8,861 donors were contacted for donor center-initiated HLA-DRB1 typing
within 1,089 donor searches. 12 of these donors have donated stem cells so far, 8 thereof for their respective target patients.
We conclude that chances of patients with ongoing donor searches to find an HLA-matched unrelated donor can indeed be
improved by donor-center initiated typing that is carried out in addition to the standard donor search process. Our results
also raise questions regarding the appropriate use of incompletely typed donors within unrelated donor searches.
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Introduction
Allogeneic hematopoietic stem cell transplantation is a well-
established and increasingly used therapy for hematological
malignancies and other severe diseases of the blood [1,2]. In the
absence of HLA-identical related donors, HLA-matched unrelated
volunteers donate hematopoietic stem cells either from bone
marrow or peripheral blood. For this purpose, national registries
have been built up since the 1970s. These registries administer
anonymous HLA data of registered donors and manage national
and international donor searches. Donor centers, on the other
hand, are responsible for education, recruitment, and HLA typing
of potential stem cell donors. Donor centers also communicate
with registered donors during the various steps of the donor search
process. Currently, about 17.0 million potential stem cell donors
are registered worldwide [3].
Full HLA typing, i.e., high-resolution typing of at least the
HLA loci A, B, C and DRB1, of newly registered potential stem
cell donors is advantageous as it reflects the current standard of
donor-recipient matching [4-6]. Due to cost and capacity
reasons, however, this typing strategy became possible only
some years ago. Therefore, the worldwide file of potential stem
cell donors that has grown for decades consists mainly of
incompletely typed donors. The existence of incompletely typed
donors on the worldwide donor file obviously complicates
unrelated donor searches and makes it possible that a fully
matching donor is not necessarily identified within a donor
search.
Available HLA phenotype data of registered donors are
routinely extended either by donor center-initiated HLA typing
(prospective typing), generally based on selection criteria as donor
age or gender or the HLA information available so far, or by
patient-related typing requests within actual donor searches. A
patient-related typing request is initiated by the responsible
transplant physician, forwarded by the national registries involved,
and executed by the donor center that has recruited the respective
donor. Figure 1 shows a schematic overview of this process.
Methods
We analyzed 9,478 donor searches between November 2009
and September 2010 that we became aware of due to patient-
related HLA typing requests for donors of DKMS German Bone
Marrow Donor Center. We then carried out additional donor
center-initiated HLA-DRB1 typing of selected donors who were so
far only typed for the HLA genes A, B and optionally C but not
DRB1 (Figure 1). Donors were selected for additional typing as
follows (Figure 2): Only patients with #2 donors on the DKMS file
who matched on 3-locus (HLA-A, -B, -DR) low-resolution
(antigen) level were considered in order to focus on difficult
searches. We then calculated for each included patient the
probability that a donor who matched on 2-locus (HLA-A, -B)
low-resolution level was also a match on the 3-locus (HLA-A, -B, -
DR) low-resolution level. Calculations were based on 3-locus low-
resolution haplotype frequencies of the German population.
Information on the HLA-C locus was – where available – not
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typing until HLA typing of one additional donor would have
increased the total probability to find at least one matching donor
for a specific patient by less than 0.5%. Younger donors were
selected first. No donors at all were selected if the calculated
individual matching probability was smaller than 0.5%. Besides,
only donors for whom a stored sample for further HLA typing was
available were included. Starting in February 2010, an age limit of
45 years was applied in the donor selection process.
We did not take into account potentially matching donors
outside the DKMS donor file in the worldwide registry as we had
no information if these donors were available, were already
requested for patient-related HLA typing, or were intentionally
not considered by the responsible transplant physicians.
HLA typing results of project donors were submitted to
registries without references to the specific patients for whom the
donors had been included in the project. Furthermore, we did not
inform the responsible transplant physicians about the donor
center-initiated typing efforts carried out in order to support the
donor searches of their patients. This approach was chosen to
avoid interferences with the standard search process. Transplant
physicians became aware of the extended HLA information of
project donors by routinely rechecking registry data during donor
searches.
Donors who were selected for donor center-initiated typing
within the project were followed-up with respect to subsequent
requests for confirmatory typing (CT; a mandatory step in the
donor search process that ensures the correctness of donor HLA
data), donor work-up (medical donor clearing and other
preparatory steps prior to donation), and stem cell donation.
At stem cell donor registration, each donor signed an informed
consent form covering sample collection and storage, HLA typing
of the sample, data storage and transmission of anonymous data to
domestic and foreign registries. All donors who were included in
the analyzed donor center-initiated typing project were informed
by mail about the continuative HLA typing.
In order to avoid delays of the donor search, we initiated HLA
typing and informed donors at the same time. Donors who
withdrew their willingness to donate stem cells, were temporarily
unavailable, or unable to donate for health-related reasons could
Figure 1. Schematic overview on the standard process of unrelated donor search (black) and the donor center-initiated typing
project (red). *: Both national registries may be identical if donor and patient live in the same country. **: The donor selection process is described
in the Methods section. An overview is given in Figure 2.Here, we present results of a project that combines donor center-initiated HLA typing with
actual donor searches. We intended to show that this approach is suited to increase chances of patients with ongoing donor searches to find
matching donors.
doi:10.1371/journal.pone.0020268.g001
Figure 2. Overview on the selection process for donor center-
initiated HLA-DRB1 typing.
doi:10.1371/journal.pone.0020268.g002
Donor Center-Initiated HLA Typing
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attached to the mail. According to their feedback, they were
temporarily or permanently excluded from the donor file. HLA
typing results of these donors were included in the analysis
regarding 3-locus low-resolution matched donors who were
identified within the project.
No ethics committee approval was obtained as donor center-
initiated typing projects are standard procedures of donor centers
that are covered by the consent form signed at recruitment.
Results
8,861 donors were contacted for additional donor center-
initiated HLA-DRB1 typing within 1,089 of the 9,478 analyzed
donor searches. Within 28 days after contact, 382 donors (4.3%)
declared their unwillingness or lack of ability to donate stem cells
or were excluded from the donor file for other reasons.
The maximum number of donors who were contacted for a
specific patient as they were potential matches based on their
HLA-A, -B low-resolution phenotypes was 70. For 179 patients,
we identified in total 236 donors who matched on the 3-locus low-
resolution level with their respective target patients.
76 confirmatory typing and 17 work-up requests were submitted
for donors with donor center-initiated HLA typing, and 12 of these
donors donated stem cells so far. 4 donor work-ups are currently
processed, one donor was unable to donate for medical reasons.
Of these requests and donations, 35 confirmatory typing requests
and 10 work-up requests were made for the original target
patients. 8 donors donated for their respective target patients, one
donor was unable to donate, and one work-up for the target
patient is currently processed.
Donations for target patients took place between 70 and 357
days (85.5 days median, 125.4 days average) after the respective
donor center-initiated typing requests. Interval lengths of the
various steps of the donor search process are shown in Table 1.
Details regarding the 8 donors who donated for their target
patients are displayed in Table 2. It shows that the study donors
were better matches than the externally requested donors in cases
1-3 and 7. In cases 4, 5 and 8, the externally requested donors
were not available for donation. In case 4, the study donor was
also a better match than the externally requested donor would
have been. In case 6, both the externally requested donor and the
study donor were 10/10 matches. As younger donors are often
preferred by transplant physicians [7], the considerably lower age
of the study donor compared to the externally requested donor (27
versus 51 years) may have been essential for the final selection
decision.
Discussion
Our practical study was intended to provide a proof of principle
if donor center-initiated HLA typing can improve the success
chances of ongoing donor searches. This proof was successfully
made.
The median and average time from donor center-initiated
typing to stem cell donation (85.5 days and 125.4 days,
respectively) suggest that donor-center initiated typing might often
be too time-consuming to support donor searches as many stem
cell transplantations are urgent. The detailed analysis of sub-
intervals in Table 1, however, shows that donor-center initiated
typing contributes only the minor part to the total interval from
donor center-initiated typing request to stem cell donation.
Besides, the average values of time interval lengths were strongly
influenced by one donor search that seemed to be not time-critical
(87 days from submission of results of donor center-initiated HLA
typing to CT request, 186 days from provision of CT sample to
work-up request). Nevertheless, it might happen in very urgent
cases that the time needed for donor center-initiated typing
prevents consideration of the requested donor for donation.
Eight donations resulted from donor center-initiated HLA
typing of more than 8,000 donors within the study. These figures
raise questions regarding the cost-benefit ratio of the analyzed
HLA typing efforts. We did not carry out a formal cost-benefit
analysis. Generally, cost-benefit analyses of ongoing donor
recruitment or continuative HLA typing of already registered
donors are complicated by several practical and ethical problems
[7–9]. The following arguments, however, suggest that it is
generally indicated to allocate resources for donor-center initiated
HLA typing as support for ongoing donor searches as described in
this work: First, 4 project donors have already donated stem cells
for patients different from the one who caused their inclusion in
the project. It is well-known that the donation probability of
registered stem cell donors depends on the completeness of their
HLA typing results [7,10,11]. It is, therefore, highly probable that
further additional donations will result from the project in the
future. Second, continuative donor center-initiated HLA typing of
already registered donors is carried out routinely by many donor
centers. Respective programs often include donor age or gender as
donor selection criteria. Here lies, apart from the focus on specific
patients, the main difference to our study that also included older
donors and did not consider donor gender. It is, however, possible
Table 1. Lengths of various intervals in the donor search process from donor center-initiated HLA typing request to stem cell
donation.
t of interval End of interval
Minimal interval
length
Maximal interval
length
Median interval
length
Average interval
length
Donor center-initiated HLA
typing request
Submission of typing results
to registry
3 29 14.8 17.5
Submission of typing results to
registry
CT request 3 87 22.9 12.5
CT request Provision of CT sample 8 18 10.9 11.5
Provision of CT sample Work-up request 2 186 42.1 19.5
Work-up request Stem cell donation 24 48 34.8 33.0
Donor center-initiated HLA typing
request
Stem cell donation 70 357 125.4 85.5
doi:10.1371/journal.pone.0020268.t001
Donor Center-Initiated HLA Typing
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initiated typing projects by inclusion of respective criteria. This is
why we introduced an age limit of 45 years. Third, the cost-benefit
ratio should be further increasable by consideration of 4-locus
high-resolution instead of 3-locus low-resolution matching prob-
abilities in the donor selection process.
Table 2. Overview on donors who donated stem cells for their respective target patients after donor center-initiated typing.
# Patient Externally requested donor Finally donating project donor
HLA HLA before request HLA Age Gender
HLA before donor
center-intiated typing HLA Age Gender
1 A*26:08,32:01, A*26:XX,32:AE, A*26:01,32:01, 44 M A26,32, 10/10 allele-level match 58 F
B*08:01,39:01, B*08:XX,39:AZRG B*08:01,38:01, B8,39
C*07:01,12:03, C*07:01,12:03,
DRB1*01:01,03:01, DRB1*01:01,03:01,
DQB1*02:01,05:01 DQB1*02:01,05:01
2 A*01:01,24:02, A*01:CNJK,01:CNJK, A*01:01,01:01, 42 F A*01:XX,24:XX, 10/10 allele-level match 54 M
B*14:02,39:06, B*14:02,39:06, B*14:02,39:06, B*14:BD,39:06
C*07:02,08:02, C*07:CESP,08:AKZ, C*07:02,08:02,
DRB1*03:01,08:01, DRB1*03:01,08:01 DRB1*03:01,08:01,
DQB1*02:01,04:02 DQB1*02:01,04:02
3 A*26:01,32:01, A*01:ENWD,26:GAX, A*01:01,26:01, 28 M A*26:KXM,32:01, 8/8 allele-level match 27 M
B*08:01,49:01, B*08:XKT,49:01, B*08:01,49:01, B*08:XX,49:01
C*07:01,07:01, C*07:CVAG,07:CVAG, C*07:01,07:01,
DRB1*03:01, 07:01 DRB1*03:01, 07:01, DRB1*03:01,07:01,
DQB1*02:01, 03:03 DQB1*02:01,03:03
4 A*11:01,32:01, A*03:CVAB,11:BDFZ, Donor not available 32 M A*11:ZPJ,32:AE, 10/10 allele-level match 41 M
B*07:02,52:01, B*07:CZZS,52:AH, B*07:AUSU,52:AE
C*07:02,12:02, C*07:WCP,12:02,
DRB1*15:02,16:01, DRB1*15:02,16:01,
DQB1*05:02,06:01 DQB1*05:02,06:01
5 A*23:01,29:02, A23,29, Donor not available 46 F A*23:XX,29:ASBU, A*23:01,29:02, 44 F
B*44:03,50:01, B44,50, B*44:ARXZ,50:MS B*44:03,50:01,
C*04:01,06:02, C*04:01,06:02,
DRB1*07:01,08:06, DRB1*07:01,08:06 DRB1*07:01,08:06,
DQB1*02:02,06:02 DQB1*03:03,06:02
6 A*02:01,24:02, A*02:DFKP,24:CWFP, 10/10 allele-level
match
51 F A*02:ARDA,24:AREC, 10/10 allele-level match 27 F
B*35:02,45:01, B*35:02,45:AH, B*35:ND,45:01
C*04:01,06:02, C*04:CVAF,06:02,
DRB1*04:05,11:04, DRB1*04:CAU,11:ATF,
DQB1*03:01,03:02 DQB1*03:01,03:02
7 A*03:01,26:01, A3,26, A3,26, 52 F A*03:XX,26:XX, 10/10 allele-level match 42 F
B*07:02,40:02, B7,61 B7,61, B*07:XX,40:CDDW
C*02:02,07:02, C2,7,
DRB1*15:01,15:01, DRB1*15:XX,15:XX DR7,15
DQB1*06:02,06:02 DQ2,6
*
8 A*02:01,26:01, A*02:GNF,26:01 Donor not available 23 M A*02:XX,26:KXM, A*02:GFFM,26:GARM, 52 M
B*07:02,55:01, B*07:02,55:01, B*07:XX,55:MZ B*07:DJJH,55:AUX,
C*03:03,07:02, C*03:03,07:02, C*03:FXFG,07:FXFR,
DRB1*13:01,14:01, DRB1*13:01,14:BCAD DRB1*13:HUJ,14:BZFS,
DQB1:05:03,06:03 DQB1*05:03,06:03
(potential 10/10
allele-level match)
Mismatches are underlined.
*: CT result as provided by transplant center.
doi:10.1371/journal.pone.0020268.t002
Donor Center-Initiated HLA Typing
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additional donor center-initiated HLA typing, confirmatory typing
and medical clearing – assessed as best available donors for their
target patients by the responsible transplant physicians had
originally not been requested for additional typing based on their
available HLA information that did not include HLA-DRB1. It is,
therefore, doubtful if they had advanced to donation without
donor center-initiated HLA typing.
This finding raises the question if there are deficiencies of the
existing donor search process regarding the use of incompletely
typed donors, especially of donors who are typed for HLA-A and -
B only. An infrequent use of donors with this typing profile has
been reported before [10]. Deficiencies of the search process
would also be consistent with observed discrepancies between
calculated [12] and reported [13,14] probabilities to find
completely matched donors for Caucasian patients.
The restriction to 3-locus low-resolution matching in the donor
selection process and the non-availability of data on patient-related
requests for non-DKMS donors within the considered donor
searches are the major limitations of the study. It is, therefore, not
possible to draw definite conclusions regarding the efficiency of the
donor search process from our results. Due to the high relevance
of this issue for optimal donor selection and thus for the best
possible patient care, further analyses of this question are urgently
required.
It is obvious that full HLA typing at donor recruitment reduces
the probability of non-finding the optimal stem cell donor. As new
donors are increasingly typed more completely due to advances in
typing technology and related cost reductions, the probability of
non-finding the optimal donor should decrease in the future.
However, there will be millions of partially typed donors in the
worldwide donor file for many years to come. There is a need for
strategies that make sure that these donors are utilized properly in
actual donor searches. Haplotype frequency-based search algo-
rithms [15,16] will probably play a major role in this effort.
Many donor centers regularly run prospective typing projects in
order to increase the completeness of HLA information of their
registered donors. Our results suggest it might be indicated to use
the funds available for such projects at least partly for donor
center-initiated HLA typing as support for currently ongoing
donor searches as described in this work. We plan, therefore, to
continue with this project with a refined donor selection process
that is based on probabilities for 4-locus high-resolution instead of
3-locus low-resolution matching.
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